ArticleACS infectious diseases2026
Development of Fluorogenic Probes to Detect Glycan-Degrading Enzymes in Bacteria.
Article in ACS infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Bacterial fitness and survival depend on the biosynthesis and maintenance of cell-envelope glycans. Bacterial glycans are composed of over 700 monosaccharides, and their construction, tailoring, recycling, and degradation require the choreographed action of myriad glycosyltransferases and glycosidases. Because of the structural diversity and complexity of bacterial glycans, coupled to limited methods to profile bacterial glycosidase activity, the function and existence of glycosidases that degrade most bacterial glycans are unknown. Taking a cue from the successful use of fluorogenic glycosides based on ubiquitous monosaccharides to detect glycosidase activity in cells and tissues, we sought to expand this approach to detect glycosidase activity in bacteria. Fluorogenic probes based exclusively on bacterial amino and deoxy sugars N-acetyl-d-fucosamine and 2,4-diacetamido-2,4,6-trideoxy-d-galactose were developed, and their activation was directly compared to a d-glucose-based fluorogenic probe in bacterial and mammalian cells. The species-selective utilization of these glycosidase probes, coupled to the difference in relative magnitude of glycosidase activity observed, provides important insights into these relatively unexplored glycan-processing enzymes. The use of these fluorogenic probes expands the toolkit for detecting glycan-degrading enzymes and offers an approach to enhancing a broader understanding of bacterial glycan metabolism and its diversity across different species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.